One meeting does not a partnership make, but Google’s interest in working with FDA on adverse event tracking should pique interest among those hoping to improve the existing systems.
To Improve Adverse Event Tracking, FDA Could Google It
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.